Insider Transactions in Q1 2023 at Repligen Corp (RGEN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Martin D Madaus |
BUY
Small Acquisition
|
Indirect |
11
+50.0%
|
$2,046
$186.22 P/Share
|
|
Mar 03
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,247
-4.89%
|
$234,436
$188.0 P/Share
|
|
Mar 03
2023
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,591
+12.34%
|
-
|
|
Mar 03
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,674
-8.8%
|
$690,712
$188.0 P/Share
|
|
Mar 03
2023
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,795
+17.4%
|
-
|
|
Mar 03
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-0.38%
|
$23,688
$188.0 P/Share
|
|
Mar 03
2023
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.12%
|
-
|
|
Mar 03
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
8,244
-4.05%
|
$1,549,872
$188.0 P/Share
|
|
Mar 03
2023
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
18,584
+8.37%
|
-
|
|
Mar 03
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-1.16%
|
$39,480
$188.0 P/Share
|
|
Mar 03
2023
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
625
+3.34%
|
-
|
|
Mar 02
2023
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,468
+13.66%
|
-
|
|
Mar 02
2023
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+12.82%
|
-
|
|
Mar 02
2023
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
3,467
+9.6%
|
-
|
|
Mar 02
2023
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
19,393
+9.49%
|
-
|
|
Mar 02
2023
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,348
+32.31%
|
-
|
|
Mar 02
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
6,670
-3.87%
|
$1,173,920
$176.37 P/Share
|
|
Mar 02
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-2.11%
|
$109,620
$174.37 P/Share
|
|
Feb 28
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
6,021
-1.7%
|
$1,041,633
$173.36 P/Share
|
|
Feb 28
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-1.49%
|
$157,776
$173.36 P/Share
|
|
Feb 28
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-2.14%
|
$141,168
$173.36 P/Share
|
|
Feb 28
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,203
-2.07%
|
$208,119
$173.36 P/Share
|
|
Feb 28
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
594
-6.1%
|
$102,762
$173.44 P/Share
|
|
Feb 16
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,647
-16.15%
|
$1,129,400
$200.0 P/Share
|
|
Feb 06
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
111
+50.0%
|
-
|